Get started
Author

Ramon De Las Peñas Bataller

Observed names: R. De Las Peñas Bataller, R. d. l. Penas, R. de la Peñas, R. de las Penas Bataller, R. de las Peñas, R. de las Peñas Bataller, Ramon De La Peñas, Ramón De La Peñas, Ramón De Las Peñas-Bataller, Ramón de las Peñas, Ramón de las Peñas Bataller
ORCID: 0000-0002-2170-4168
Observed ORCID: 0000-0002-2170-4168
OpenAlex ID: A5022488184
SEOM clinical guidelines on nutrition in cancer patients (2018)
2019 · R. de las Peñas, M. Majem, et al. · Clinical & Translational Oncology · 135
SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
2021 · Y. Escobar Álvarez, R. de las Peñas Bataller, et al. · Clinical & Translational Oncology · 34
Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain
2013 · C. Balañá, M. A. Vaz, et al. · Clinical & Translational Oncology · 15
Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07
2017 · Nuria Viñolas, Pilar Garrido, et al. · Cancer Investigation · 12
100MO Olaparib maintenance vs placebo in platinum-sensitive non-small cell lung cancer: The phase II randomized PIPSeN trial
2021 · S. Postel-Vinay, D. Planchard, et al. · Journal of Thoracic Oncology · 9
Lung cancer in Spanish women: The WORLD07 project
2018 · Pilar Garrido, Nuria Viñolas, et al. · European Journal of Cancer Care · 7
PDF
Fractionated stereotactic radiotherapy plus bevacizumab after response to bevacizumab plus irinotecan as a rescue treatment for high-grade gliomas
2015 · Antonio José Conde-Moreno, Raquel García-Gómez, et al. · Reports of Practical Oncology & Radiotherapy · 6
PDF
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
2023 · L. Gately, C. Mesía, et al. · Journal of Neuro-Oncology · 5
Reservorios venosos subcutáneos: disección versus punción
2003 · Andrés Armelles Flors, I. Busquier, et al. · Oncología (Barcelona) · 4
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)
2024 · Lucy Gately, C. Mesía, et al. · Journal of Neuro-Oncology · 2
Adherence to the Sociedad Española de Oncología Médica (SEOM) Algorithm for the Treatment of Hyponatremia in Oncology Patients in Spain: The ALGA Study
2020 · Fernando Henao, Aranzazu Manzano, et al. · Advances in Therapy · 2
1069P A multicenter phase II study of nivolumab combined with ipilimumab in patients with pediatric solid tumours in adulthood (GETHI021)
2020 · X. Mielgo Rubio, R. Diaz-Beveritge, et al. · Annals of Oncology · 1
P17.35 * Geino-10: a Prospective Observational Multicenter Study of the Characteristics of Patients With Intra-axial Brain Tumours and Their Therapeutic Management in Spanish Hospitals
2014 · M. J. Gil-Gil, J. M. Sepulveda, et al. · Neuro-Oncology · 1
Ctni-54. a Combined Analysis of Two Randomised Studies Exploring the Impact of Extended Post-radiation Temozolomide on Survival Outcomes in Newly Diagnosed Glioblastoma
2023 · Lucy Gately, Carlos Mesia, et al. · Neuro-Oncology
PDF
Correction to: SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
2021 · Y. Escobar Álvarez, R. de las Peñas Bataller, et al. · Clinical & Translational Oncology
Impact of surgery versus other treatment options in recurrent glioblastoma. Analysis of the Spanish Group of Neurooncology Research (GEINO) RETSINE database.
2021 · María Ángeles Vaz Salgado, Isaac Ceballos Lenza, et al. · Journal of Clinical Oncology
Elderly glioblastoma patients: Survival analysis according adjuvant therapy and tumor molecular analysis.
2021 · Maria Angeles Vaz, Isaac Ceballos Lenza, et al. · Journal of Clinical Oncology
NORA trial (GECP 15/02): Updated results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)
2019 · M. Guirado, M. Majem, et al. · Annals of Oncology
Updated analysis of the national registry of nervous system tumours in Spain (RETSINE). RETSINE: National registry of nervous system tumours of the Spanish research group in neuro-oncology (GEINO) and Spanish infrequent and orphan tumours group (GETHI)
2019 · I. Ceballos Lenza, P. Perez Segura, et al. · Annals of Oncology
PDF
BRCA1 expression level as prognostic factor for recurrence in resected NSCLC with adjuvant chemotherapy: SCAT Trial
2019 · B. Massuti Sureda, J.M. Sanchez Torres, et al. · Annals of Oncology
Extending temozolomide longer than six cycles in glioblastoma: Results of the randomized GEINO-014 trial
2019 · M.A.V. Salgado, J.M. Sepulveda Sanchez, et al. · Annals of Oncology
PDF
Control de síntomas en la población de la 3ª edad
2018 · Ramón de las Peñas Bataller · Anales (Reial Acadèmia de Medicina de la Comunitat Valenciana)
P17.04 * Rano Criteria Applied to a Phase Ii Randomized, Multicenter Trial Comparing Temozolomide (tmz) Vs Tmz-plus-bevacizumab (bev) Before Standard Treatment in Unresectable Glioblastoma (gbm) Patients (p).genom 009 Study by the Geino Group
2014 · C. Balana, R. d. l. Penas, et al. · Neuro-Oncology
Ep-1025 Rescue Treatment for High Grade Gliomas Through Hypofractionated Rt+ Bevacizumab. Experimental Study
2012 · V. González Vidal, A. Conde Moreno, et al. · Radiotherapy and Oncology
Supplementary Material 10
2009 · Rafael Rosell, Laia Perez‐Roca, et al.
Works count: 25
Citation count: 233
H-index: 6
I10-index: 4
Year
Topic
Type